Yeah I was very impressed on all fronts; the way he straddled the gene therapies and exon skips with our approach, including our difference to the competitions efforts at reducing inflammation.
The science was just deep enough, but Ive learnt to somewhat understand it now (room to grow of course) for serious investors to take a proper look at. As mentioned on the other more informative thread - these guys arent goldmansachs but theyre not a nobody either.
A few of my grey areas in the science were answered which is awesome, very confident now.
PER - Megathread, page-239
-
- There are more pages in this discussion • 88 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
